1. Home
  2. MBOT vs GALT Comparison

MBOT vs GALT Comparison

Compare MBOT & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBOT
  • GALT
  • Stock Information
  • Founded
  • MBOT 2010
  • GALT 2000
  • Country
  • MBOT United States
  • GALT United States
  • Employees
  • MBOT N/A
  • GALT N/A
  • Industry
  • MBOT Medical/Dental Instruments
  • GALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • MBOT Health Care
  • GALT Health Care
  • Exchange
  • MBOT Nasdaq
  • GALT Nasdaq
  • Market Cap
  • MBOT 94.6M
  • GALT 83.5M
  • IPO Year
  • MBOT N/A
  • GALT N/A
  • Fundamental
  • Price
  • MBOT $2.60
  • GALT $2.52
  • Analyst Decision
  • MBOT Strong Buy
  • GALT Buy
  • Analyst Count
  • MBOT 1
  • GALT 2
  • Target Price
  • MBOT $9.00
  • GALT $6.00
  • AVG Volume (30 Days)
  • MBOT 998.8K
  • GALT 1.5M
  • Earning Date
  • MBOT 08-13-2025
  • GALT 08-12-2025
  • Dividend Yield
  • MBOT N/A
  • GALT N/A
  • EPS Growth
  • MBOT N/A
  • GALT N/A
  • EPS
  • MBOT N/A
  • GALT N/A
  • Revenue
  • MBOT N/A
  • GALT N/A
  • Revenue This Year
  • MBOT N/A
  • GALT N/A
  • Revenue Next Year
  • MBOT N/A
  • GALT N/A
  • P/E Ratio
  • MBOT N/A
  • GALT N/A
  • Revenue Growth
  • MBOT N/A
  • GALT N/A
  • 52 Week Low
  • MBOT $0.82
  • GALT $0.73
  • 52 Week High
  • MBOT $3.38
  • GALT $3.90
  • Technical
  • Relative Strength Index (RSI)
  • MBOT 54.60
  • GALT 63.30
  • Support Level
  • MBOT $2.44
  • GALT $2.07
  • Resistance Level
  • MBOT $2.77
  • GALT $2.36
  • Average True Range (ATR)
  • MBOT 0.13
  • GALT 0.27
  • MACD
  • MBOT 0.01
  • GALT -0.01
  • Stochastic Oscillator
  • MBOT 63.83
  • GALT 61.64

About MBOT Microbot Medical Inc.

Microbot Medical Inc is a clinical-stage medical device company specializing in the research, design and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is focused on leveraging its robotic technologies to redefine surgical robotics while improving surgical outcomes for patients. Using its LIBERTY technological platform, the company is developing the first-ever fully disposable robot for various endovascular interventional procedures.

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Share on Social Networks: